Including AMR in Pandemic Instrument Design: Opportunities and Challenges
Tuesday June 21, 2022
In 2021, the World Health Assembly agreed to a global process to draft and negotiate an international instrument focused on addressing future pandemic threats. This webinar explores the pandemic threat posed by AMR and the opportunities and challenges related to synergistically designing a pandemic instrument that addresses silent pandemics like AMR alongside novel zoonotic pandemics. Practical measures needed to mitigate AMR will be discussed, including surveillance considerations, equitable access to medical countermeasures and combatting inequities in policy planning regarding capacity and facility needs in low- and middle-income countries.
Related Readings
Addressing Antimicrobial Resistance through Negotiation of a Pandemic Instrument. May 2022. Global Strategy Lab.
Learning from Covid-19 to Tackle Antibiotic Resistance. November 2020. GARDP.
Panelists
Susan Rogers Van Katwyk is the Research Director, Global Antimicrobial Resistance at the Global Strategy Lab and Managing Director of the WHO Collaborating Centre on Global Governance of Antimicrobial Resistance at York University. Susan’s research focuses on strengthening the scientific evidence base to generate actionable evidence-informed policy recommendations for global health threats that require global collective action. Susan has a PhD in Epidemiology from the University of Ottawa.
Rohit Malpani is a policy consultant for the Global Antibiotic Research and Development Partnership. Previously he was the Director of Policy for the Medecins Sans Frontieres Access Campaign, a Special Advisor to Oxfam, and a human rights advisor to the World Health Organization. Rohit is also currently a Board Member to Unitaid representing non-governmental organizations. He is an attorney by training.
Otto Cars is the Founder and Senior advisor of ReAct- Action in Antibiotic Resistance. He holds a position as Senior Professor of Infectious Diseases and Antimicrobial Resistance at Uppsala University. He has served as an expert to the World Health Organization and several European Agencies and was a member of the UN ad hoc Interagency Coordination Group on Antimicrobial Resistance (IACG).
Moderator
Steven J. Hoffman is the Dahdaleh Distinguished Chair in Global Governance & Legal Epidemiology and a Professor of Global Health, Law, and Political Science at York University, the Director of the Global Strategy Lab, the Director of the WHO Collaborating Centre on Global Governance of Antimicrobial Resistance, and the Scientific Director of the CIHR Institute of Population & Public Health at the Canadian Institutes of Health Research.
Previous